IOP-Lowering Efficacy of Brinzolamide 1.0% Added to Travoprost 0.004%/Timolol 0.5% Fixed Combination as Adjunctive Therapy
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00382226 |
Recruitment Status :
Completed
First Posted : September 28, 2006
Last Update Posted : November 18, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Glaucoma | Drug: Azopt | Phase 4 |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 195 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double |
Primary Purpose: | Treatment |
Official Title: | IOP-Lowering Efficacy of Brinzolamide 1.0% Added to Travoprost 0.004%/Timolol 0.5% Fixed Combination as Adjunctive Therapy |
Study Start Date : | September 2006 |
Actual Primary Completion Date : | August 2007 |
Actual Study Completion Date : | August 2007 |

- IOP lowering
- safety

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Glaucoma
Exclusion Criteria:
- Under 18

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00382226
Australia, New South Wales | |
Sydney Study Site | |
Sydney, New South Wales, Australia, 2000 |
Study Director: | Mark Jasek | Alcon Research |
Responsible Party: | Alcon Research |
ClinicalTrials.gov Identifier: | NCT00382226 |
Other Study ID Numbers: |
CM-05-10 |
First Posted: | September 28, 2006 Key Record Dates |
Last Update Posted: | November 18, 2016 |
Last Verified: | April 2008 |
Glaucoma |
Glaucoma Ocular Hypertension Eye Diseases |